Notification No.161/2023: Amendment of the Drug Registration Notification

Notifying member
Myanmar
Title
Notification No.161/2023: Amendment of the Drug Registration Notification
First published
30/10/1992
First EIF
01/01/2024
Latest published
01/04/2014
In force to
Latest notification
G/LIC/N/2/MMR/13
Product categories
List of products subject to licensing
Nature of licensing

Non-automatic

Administrative purpose/measure being implemented
  • Protect human, animal or plant life and health; protect environment
Administrative body(ies) for submission of applications
Department of Food and Drug Administration, Ministry of Health and Sports
Pyigyi Zayyar Road, Zayya Theiddhi Ward, Zabu Thiri Township, Nay Pyi Taw, Myanmar
http://www.fdamyanmar.gov.mm
+95 67 3403609

fdanpt1@gmail.com

Contact point for information on eligibility

Same as the "Administrative bodies"

Expected duration of licensing procedure
Ongoing
Found by secretariat
No
Related document symbols
  • G/LIC/N/2/MMR/1
  • G/LIC/N/2/MMR/12
Notes
  • G/LIC/N/2/MMR/1


    The National Drug Law 1992


    The National Drug Law Amendment 2014

    According to the National Drug Law, the DFDA only issues the Drug Importation Approval Certificate after checking the Goods Storage Practice and Goods Distribution Practice.


  • G/LIC/N/2/MMR/12

    According to National Drug Law, Notification No. 3/1993 is concerned with registration of pharmaceuticals in Myanmar describing the requirements for drug registration.


  • G/LIC/N/2/MMR/13


    Notification No.161/2023: Amendment of the Drug Registration Notification


    Modification: Administrative purpose, Duration of licensing, Documentation requirements (including application form), Processing time for issuing licence, Licence fee/administrative charge


    Article 1


    1.(a) According to the section 7 of the National Drug Law, a person who wants to register a drug must apply to the Department of Food & Drug Administration.


    (b) An application under sub-article (a) may be registered using e-submission system.


    (c) When applying according to sub-article (b), the information in this system must be completed and applied correctly.


    (d) Submission of drug sample and specific documents must be complied with Drug Registration Guideline by the Department of Food and Drug Administration.


    2. After the description of Article 6 of the Drug Registration Notification, E-submission application to the Department of Food and Drug Administration must be made via online payment system.


    3. Article10


    (a) For imported registered drugs, the prescribed annual fees must be paid regularly via online payment system during validity period of Drug Registration Certificate. If annual fees are dismissed for two consecutive years, the renewal registration will not be allowed.


    (b) Imported registered drugs must be submitted to the Department of Food and Drug Administration for laboratory testing, once every five years of registration, and the Laboratory analysis fee must be paid via online payment system.


    (c) For local registered drugs, an annual GMP inspection of plant by the Department of Food and Drug Administration and random sampling and testing of high-risk drugs must be complied.


    4. Article 11


    A person who wishes to apply for renewal Registration certificate must apply in accordance with the specific requirements on 6 months before the expiry of the drug registration certificate.


    5. The term "Myanmar Food and Drug Authority" stated in Articles 7, 8, 9, 10 and 13 of the Drug Registration Notification shall be replaced by "Department of Food and Drug Administration assigned by the Myanmar Food and Drug Authority".